Ireland Cancer Pain Management Market Analysis Report [2022-30]

Ireland Cancer Pain Management Market Analysis

$ 3999

Ireland's Cancer Pain Management market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-2030. The main factors driving the growth would be aging populations, government support and initiatives, rising cancer incidences, and rising demand for pain management solutions. The market is segmented by drug type and by disease. Some of the major players include Endo International (IRL), Medtronic (IRL), Grunenthal Pharma, Pfizer, Teva Pharmaceuticals, and Abbott.

ID: IN10IEHS002 CATEGORY: Healthcare Services GEOGRAPHY: Ireland AUTHOR: Neha Davda

Buy Now

Ireland Cancer Pain Management Market Executive Summary

Ireland's Cancer Pain Management market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Ireland's national healthcare spending as a share of GDP in 2019 was 6.68% or $5,429 per person. Ireland spends almost as much per person on healthcare as the EU average.

Cancer itself or treatments like surgery and chemotherapy that are used in conjunction with it can both lead to pain from the disease. The selection and usage of medications are influenced by the type, location, and pain intensity experienced. A number of medications are used to relieve the pain brought on by cancer. It is recommended to utilize strong opioids rather than non-opioids like acetaminophen and NSAIDs in cases of severe pain while treating mild to moderate cancer pain, for instance. Europe is a recognized player in the global market for the treatment of cancer pain, and it is also home to some of the leading pharmaceutical firms that are actively engaged in the creation of novel analgesics. Ireland has the second highest overall cancer rate (men and women combined), at 326.6 per 100,000.

Market Dynamics

Market Growth Drivers

Aging populations, government support and initiatives, rising cancer incidences, and rising demand for pain management solutions are all anticipated to have a positive impact on the Ireland cancer pain management market. Ireland has the second highest overall cancer rate (men and women combined), at 326.6 per 100,000.

Market Restraints

Some pain relievers include side effects such as nausea, dizziness, urinary incontinence, sleep issues, and constipation, which can limit their use and have an impact on the growth of the cancer pain management market. Also, Cancer pain can be difficult to accurately diagnose and monitor, which can prevent patients from receiving the appropriate care and limit the market growth.

Competitive Landscape

Key Players

Endo International (IRL)
Medtronic (IRL)
Grunenthal Pharma
Pfizer
Teva Pharmaceuticals
Abbott

Notable Recent Deals

July 2022: Medtronic entered into a strategic partnership with CathWorks, a coronary artery disease (CAD) technology developer. In accordance with the agreement, Medtronic will contribute up to $75 million and start co-promoting CathWorks' FFRangio system which is commercially accessible in the U.S., Europe, and Japan. Following the achievement of some unspecified milestones, a separate agreement gives Medtronic the option to purchase CathWorks.

Healthcare Policies and Regulatory Landscape

In Ireland, the Health and Social Care Professionals Council (CORU) and the Health Products Regulatory Authority (HPRA) are largely in charge of regulating the field of pain treatment. These organizations are in charge of establishing standards of practice and making sure that healthcare providers and products adhere to high standards of quality and safety.

A number of policy initiatives have also been implemented by the Irish government with the goal of improving chronic pain management in Ireland. Included in this is the National Chronic Pain Strategy, which specifies a thorough method for diagnosing, treating, and managing chronic pain as well as the creation of a National Pain Management Centre.

Reimbursement Scenario

The Irish Health Services Executive (HSE), which is in charge of running the public health system in Ireland, is largely responsible for establishing payment guidelines for pain management. The HSE establishes the payment rates for healthcare services and treatments that fall within the public health insurance program.

The HSE offers a variety of services for pain management, including prescription drugs, physiotherapy, and some specialist consultations. Some treatments, such as surgery and specific procedures, could need prior HSE approval and might not always be covered. Treatments for pain management are also covered by private health insurance, however, the level of coverage and reimbursement rates may differ between insurers.

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Cancer Pain Management Market Segmentation

By Drug Type (Revenue, USD Billion):

Non-steroidal anti-inflammatory medicines relieve pain at the site of injury by blocking the cyclooxygenase enzyme, which prevents prostaglandin formation. NSAIDs are a class of medications that includes medications with analgesic, antipyretic, and, at higher doses, anti-inflammatory properties.

Opioids
Morphine
- Fentanyl
- Others
Non-Opioids
Acetaminophen
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Nerve Blockers

By Disease Indication (Revenue, USD Billion):

Based on disease Indication the market is segmented into:

Lung Cancer
Colorectal cancer
Breast cancer
Prostate cancer
Blood cancer
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.